ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 243 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $7,688,000 | +61.0% | 82,718 | +3.2% | 0.01% | +50.0% |
| Q3 2021 | $4,774,000 | -17.0% | 80,171 | -4.9% | 0.01% | -14.3% |
| Q2 2021 | $5,750,000 | -5.5% | 84,317 | -3.8% | 0.01% | -12.5% |
| Q1 2021 | $6,084,000 | -10.1% | 87,677 | -0.4% | 0.01% | -11.1% |
| Q4 2020 | $6,765,000 | +2.8% | 88,049 | +0.0% | 0.01% | -18.2% |
| Q3 2020 | $6,582,000 | +23.1% | 88,006 | +3.6% | 0.01% | +22.2% |
| Q2 2020 | $5,345,000 | +65.8% | 84,912 | +10.6% | 0.01% | +28.6% |
| Q1 2020 | $3,224,000 | -8.0% | 76,758 | -0.5% | 0.01% | +16.7% |
| Q4 2019 | $3,504,000 | -1.7% | 77,138 | -0.9% | 0.01% | -14.3% |
| Q3 2019 | $3,563,000 | -21.0% | 77,854 | +1.2% | 0.01% | -22.2% |
| Q2 2019 | $4,510,000 | +32.4% | 76,924 | +1.2% | 0.01% | +28.6% |
| Q1 2019 | $3,407,000 | +12.6% | 76,008 | -2.2% | 0.01% | 0.0% |
| Q4 2018 | $3,026,000 | -13.2% | 77,698 | +2.5% | 0.01% | 0.0% |
| Q3 2018 | $3,487,000 | +5.3% | 75,776 | -0.3% | 0.01% | 0.0% |
| Q2 2018 | $3,312,000 | +14.9% | 75,973 | +4.1% | 0.01% | +16.7% |
| Q1 2018 | $2,883,000 | +36.9% | 72,984 | +17.7% | 0.01% | +50.0% |
| Q4 2017 | $2,106,000 | +31.2% | 61,983 | -1.5% | 0.00% | 0.0% |
| Q3 2017 | $1,605,000 | +67.5% | 62,932 | +10.8% | 0.00% | +100.0% |
| Q2 2017 | $958,000 | – | 56,796 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |